24.18
3.47%
-0.87
Dopo l'orario di chiusura:
24.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DNLI Giù?
Forum
Previsione
Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
14.54
|
- | 1.267 | 294.12 | 35.14 |
Operating Expenses
|
0.24%
132.25
|
132.57 | 115.06 | 123.64 | 155.96 |
Benefits Costs and Expenses |
116.34
|
- | - | - | - |
Costs And Expenses |
0.24%
132.25
|
132.57 | 115.06 | 123.64 | 155.96 |
Operating Income/Loss |
11.21%
-117.72
|
-132.57 | -113.80 | 170.48 | -120.81 |
Income/Loss From Continuing Operations Before Tax |
-101.80
|
- | 1.267 | 294.12 | 35.14 |
Income/Loss From Continuing Operations After Tax |
14.79%
-101.80
|
-119.47 | -99.35 | 183.38 | -109.78 |
Net Income/Loss
|
14.79%
-101.80
|
-119.47 | -99.35 | 183.38 | -109.78 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
50,597%
149.40
|
0.2947 | 137.64 | 137.05 | 136.52 |
Diluted Average Shares |
50,597%
149.40
|
0.2947 | 137.64 | 140.93 | 136.52 |
Basic Earnings Per Share |
21.84%
-0.68
|
-0.87 | -0.72 | 1.34 | -0.80 |
Diluted Earnings Per Share |
21.84%
-0.68
|
-0.87 | -0.72 | 1.30 | -0.80 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):